June 20, 2023, Research Bulletin

Dear Research Community Colleagues, 

We hope that your summer is off to a great start. 

Please note, the Research Bulletin will not be distributed on Tuesday, July 4, 2023. It will resume again on Tuesday, July 18, 2023.   As a reminder, the Research Bulletin is disseminated on the first and third Tuesday of each month. 

If you have questions or comments regarding format, or content ideas, please email researchadmincomm@cuanschutz.edu. 

Enjoy your summer and the upcoming holiday! 

Sincerely, Thomas Flaig, MD
Vice Chancellor for Research
University of Colorado Denver | Anschutz

Featured Funding Opportunities

NIH Funding 

• 09/28/23 — NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed)
• 10/11/23 — Development of Software for Data Science in Infectious and Immune-Mediated Diseases Research (U01 Clinical Trial Not Allowed)
• 10/18/23 — HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)
• 10/18/23 — Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed)

DOD Funding

• Neurofibromatosis Research Program (NFRP) – 8 funding mechanisms
• Kidney Cancer Research Program (KCRP) – 7 funding mechanisms
• Reconstructive Transplant Research Program (RTRP) – 3 funding mechanisms
• Duchenne Muscular Dystrophy Research Program (DMDRP) – 2 funding mechanisms 

ARPA-H 

• 6/23/23 (Abstract) 7/28/2023 (Full) — Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) Program Broad Agency Announcement (BAA)
• 3/23/2024 — Open-Office Broad Agency Announcement (BAA); abstracts accepted on a rolling basis

Notices of Intent to Publish

NIH

10/23/2023 — Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional)

NIH Funding Announcements

Limited Funding Opportunities

Special Announcements

Countdown to July 1st - New CU Anschutz IND/IDE Program Launch

The newly created IND/IDE Office is part of the CU Anschutz-wide IND/IDE Program, a partnership between the Office of the Vice Chancellor for Research and the Cancer Center. The program will manage and track all communications and submissions to FDA and all documents submitted to FDA throughout a project’s lifecycle.

The IND/IDE Office will officially open July 1, 2023!

Important items to know as July 1st approaches:

• Active INDs and IDEs may transition into management by the IND/IDE program on a case-by-case basis. 
• There will be a single point of entry to initiate collaboration with IND/IDE program staff for any communication with the FDA regardless of therapeutic indication or details of your request. You can find the triage intake link and more information about the IND/IDE Office on their website.
• Study teams will need to initiate collaboration with IND/IDE program staff before and separate from the HSR Portal as soon as they have a final draft of the protocol, or whenever they see the potential need for interaction with FDA.
• The IND/IDE Program will assist with project feasibility assessments including an administrative budget review in accordance with their internal workflows. These steps will help support PIs in conducting successful and viable clinical trials.
• For any questions or to request additional information, please contact the IND/IDE Office at ind.ide.office@cuanschutz.edu.

Develop a novel therapeutic, medical device, or diagnostic with a $200,000 SPARK|REACH award

What's Included: SPARK Awards bridge the gap between academic discovery and the clinic through product development-based funding and hands-on advising from
industry experts.

• Mentorship: 1:1 project management support and a customized program that adapts to the needs of each project
• Industry Network: Access to industry and subject matter experts experienced in commercialization, pharmaceutical and medtech product development, and regulatory, reimbursement and go-to-market strategy
• Education & Resources: Access to the SPARK Bootcamp, designed specifically to support you in the preparation of the full application

Important Dates:

• June 19: Applications open
• August 2: Letters of intent due
• August 23: Start of bootcamp
• September 27: Full applications due

For more information click here. 

Join the ongoing dialogue and work to enhance DEI and recruitment in clinical research!

This is a follow-up to the March 10th Sharing Experiences and Collaborating to Expand Research Recruitment workshop, but all are welcome to join as your schedule allows.

The first hour will include structured information and updates, while the second hour will be available for optional informal discussions. 

Date: Friday, June 30, 2023
Time: 9-10am Structured Meeting; 10-11am Optional Informal Discussion
Location: Krugman Conf. Hall, Trivisible or Zoom 

For additional questions and Zoom details please contact Jama Bettis.

Orthopedic Research Symposium & D’Ambrosia Diversity Lectureship

This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.   

Past Research Bulletins can be found here.

Please click here if you wish to be added to this distribution.